Cancer Drug Discovery & Preclinical Development

Hear in-depth presentations on a range of key issues of interest to those working in early stage oncology research and development. Topics include:

Improving the Efficiency and Effectiveness of Cancer Drug Discovery
Building and Maintaining Industry-Academia Alliances in Oncology
Acquired Resistance to Targeted Kinase Inhibitors – Causes, Consequences & Solutions
Discovery of a Novel Inhibitor of mTOR Pathway in Clinical Development
Novel RNA Oligonucleotide that Inhibits Liver Carcinogenesis In Vivo
Using Preclinical Data to Inform Clinical Dose & Schedule in Cancer Drug Trials
Using Multi-Scale Modelling to Support Preclinical Developments
Preclinical Models for Drug Discovery & Translating Combination Approaches to Clinical Trials